Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Buy WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX)? – Alere Inc (NYSE:ALR), Genomic Health, Inc. (NASDAQ:GHDX)

WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX) shareholders have witnessed an increase in enthusiasm from smart money of late.

To the average investor, there are plenty of gauges shareholders can use to analyze their holdings. Two of the most under-the-radar are hedge fund and insider trading sentiment. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the elite hedge fund managers can beat their index-focused peers by a very impressive amount (see just how much).

WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX)

Just as key, bullish insider trading sentiment is another way to break down the financial markets. Obviously, there are a number of stimuli for an insider to get rid of shares of his or her company, but just one, very simple reason why they would buy. Several empirical studies have demonstrated the valuable potential of this method if you understand what to do (learn more here).

Now, we’re going to take a look at the key action regarding WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX).

What have hedge funds been doing with WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX)?

At year’s end, a total of 12 of the hedge funds we track were long in this stock, a change of 33% from one quarter earlier. With hedgies’ sentiment swirling, there exists an “upper tier” of noteworthy hedge fund managers who were increasing their stakes substantially.

According to our comprehensive database, Julian Robertson’s Tiger Management had the biggest position in WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX), worth close to $18 million, comprising 3.2% of its total 13F portfolio. On Tiger Management’s heels is D. E. Shaw of D E Shaw, with a $4 million position; the fund has 0% of its 13F portfolio invested in the stock. Remaining hedgies that are bullish include Mario Gabelli’s GAMCO Investors, Jacob Gottlieb’s Visium Asset Management and Jim Simons’s Renaissance Technologies.

As one would reasonably expect, specific money managers were breaking ground themselves. Highland Capital Management, managed by James Dondero, assembled the biggest position in WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX). Highland Capital Management had 1 million invested in the company at the end of the quarter. Mike Vranos’s Ellington also initiated a $0 million position during the quarter. The only other fund with a brand new WX position is Bruce Kovner’s Caxton Associates LP.

How are insiders trading WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX)?

Insider trading activity, especially when it’s bullish, is best served when the company we’re looking at has seen transactions within the past 180 days. Over the last 180-day time period, WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX) has seen zero unique insiders buying, and zero insider sales (see the details of insider trades here).

Let’s also take a look at hedge fund and insider activity in other stocks similar to WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX). These stocks are Bio-Reference Laboratories Inc (NASDAQ:BRLI), Alere Inc (NYSE:ALR), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), ICON plc – Ordinary Shares (NASDAQ:ICLR), and Genomic Health, Inc. (NASDAQ:GHDX). All of these stocks are in the medical laboratories & research industry and their market caps are similar to WX’s market cap.

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Bio-Reference Laboratories Inc (NASDAQ:BRLI) 10 0 2
Alere Inc (NYSE:ALR) 24 0 3
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) 11 0 3
ICON plc – Ordinary Shares (NASDAQ:ICLR) 16 0 0
Genomic Health, Inc. (NASDAQ:GHDX) 13 2 8

With the results exhibited by the aforementioned time-tested strategies, everyday investors must always monitor hedge fund and insider trading sentiment, and WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX) applies perfectly to this mantra.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!